Sep 14, 2021 / 02:50PM GMT
Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
All right. Good morning, everyone. Thank you for joining us. I think we're going to get started. My name is Jeff Johnson. I'm the senior medical technology analyst at Baird. Our next presentation this morning is from Zimmer Biomet, a leader in the $37 billion global orthopedic market. With us today from Zimmer, we're very happy to have CEO, Bryan Hanson; and CFO, Suketu Upadhyay. Bryan and Suky, I think we're just going to go straight into Q&A. It sounds like we didn't have any prepared remarks. So I usually turn it over to you for that. But let's just go straight into Q&A.
Questions and Answers:
Jeffrey D. Johnson - Robert W. Baird & Co. Incorporated, Research Division - Senior Research AnalystAnd Bryan, I'm sure the question you're getting a million times, so I apologize and it's short-term focused, so I apologize for that as well. But orthopedic end markets. I want to focus most of our time today on strategic longer-term decisions, but
Trustpilot
